IGF-1 LR3 · Performance
IGF-1 LR3 dosage by bodyweight
Reference dose ranges scaled across bodyweight bands, anchored to the most-cited research dose (20 mcg @ 75 kg). Educational only — never a recommendation.
| Bodyweight band | Reference dose range | At U-100 (1 mg/mL) | Vol. on U-100 (5 mg / 2 mL) | 5× t½ elapsed |
|---|---|---|---|---|
| <60 kg / <132 lb | 12–17 mcg | 0.01–0.02 mL | 1–1 units0.00–0.01 mL | 5.0 d |
| 60–75 kg / 132–165 lb | 15–21 mcg | 0.01–0.02 mL | 1–1 units0.01–0.01 mL | 5.0 d |
| 75–90 kg / 165–198 lb | 19–25 mcg | 0.02–0.03 mL | 1–1 units0.01–0.01 mL | 5.0 d |
| 90–105 kg / 198–231 lb | 22–30 mcg | 0.02–0.03 mL | 1–1 units0.01–0.01 mL | 5.0 d |
| >105 kg / >231 lb | 26–35 mcg | 0.03–0.04 mL | 1–1 units0.01–0.01 mL | 5.0 d |
Volume column assumes a standard 5 mg vial reconstituted with 2 mL bacteriostatic water (concentration 2.5 mg/mL); insulin units shown for a U-100 syringe. Five half-lives is the conventional washout window where ~3% of peak plasma remains — a useful "next dose due" anchor for IGF-1 LR3 (t½ 1.0 d).
IGF-1 LR3 by goal
Read IGF-1 LR3's profile and dosing through a specific research-goal lens.
⚠
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.